Do you extrapolate from uveitis treatment pathways when managing other inflammatory eye conditions such as atypical serpiginous choroiditis?

I do tend to apply these principles. So these entities like serpiginous, relentless placoid, etc., I would consider posterior uveitis. While we definitely do not fully understand the full pathophysiology of all these diseases, there is good evidence of inflammatory activity, hence response to steroids or immunomodulation. However, there is disagreement whether certain entities (like PIC) truly respond to this type of therapy. In cases that are progressive or vision threatening, I would treat no ...

Serpiginous Choroiditis is a rare recurrent eye disorder with unknown etiology. The disease tends to be progressive, bilateral, and noninflammatory. In my review and experience, treatment is not indicated unless the fovea of the retina is affected whereby a trial of systemic treatment may be considered. The response and efficacy are hard to gauge due to limited data. My approach is to manage these patients similar to those with posterior uveitis or uveitis associated with Behcet's syndrome. The ...